This content is machine translated Artificial intelligence for COPD A new era of personalized treatment Chronic obstructive pulmonary disease (COPD) remains one of the leading causes of morbidity and mortality worldwide. The development of artificial intelligence (AI) has led to new ways of effectively treating...…
View Post 8 min This content is machine translated Clinical significance, pathophysiology, diagnosis and management Frailty in COPD Frailty has established itself as a central concept in modern pulmonology in recent years. While the syndrome was originally described primarily as a geriatric phenomenon, more recent data shows that...…
View Post 15 min This content is machine translated Pulmonary hypertension PH and lung diseases Pulmonary hypertension (PH) describes a hemodynamic condition with a pathological increase in pressure in the pulmonary vascular circulation. Clinically, PH causes reduced performance, shortness of breath, angina and syncope. Comprehensive...… CME-Test
View Post 11 min This content is machine translated COPD therapy Drug therapy – Update 2025 Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory multisystem disease caused primarily by inhaled noxious substances in combination with environmental factors and genetic predispositions. The presence of such a...… CME-Test
View Post 6 min This content is machine translated COPD and comorbidities Exacerbation frequency is associated with cardiopulmonary disease burden Exacerbation severity and frequency are crucial for the prognosis of COPD, but also appear to have a major impact on the course of comorbidities. There is a growing body of...…
View Post 4 min This content is machine translated COPD exacerbations Fast therapy initiation is not much better than expected Studies have shown that the immediate initiation of inhaled triple therapy with a single inhaler immediately after a COPD exacerbation achieves better therapeutic effects than delayed initiation. However, Canadian scientists...…
View Post 11 min This content is machine translated COPD therapy Drug therapy – Update 2025 Chronic obstructive pulmonary disease ( COPD) is a chronic inflammatory multisystem disease caused primarily by inhaled noxious substances in combination with environmental factors and genetic predispositions. The presence of such...… CME-Test
View Post 5 min This content is machine translated Long-COVID Increased risk with asthma and COPD Long-COVID is rapidly becoming one of the most common chronic diseases worldwide. However, the pathogenic mechanisms underlying the development of this new disease are still largely poorly understood. Recent evidence...…
View Post 5 min This content is machine translated Rehospitalization risk for cardiopulmonary diseases Transition to the outpatient setting is crucial There are various reasons why patients with chronic lung diseases experience renewed exacerbations and associated rehospitalizations after discharge from hospital. The most vulnerable patient groups are those with comorbidities such...…
View Post 9 min This content is machine translated Chronic lung diseases Sarcopenia and malnutrition in the context of pneumological rehabilitation Malnutrition and sarcopenia are two common but often underestimated complications in patients with chronic lung diseases such as COPD, pulmonary fibrosis or other respiratory diseases. Both conditions have a profound...… CME-Test
View Post 5 min This content is machine translated COPD Better outcomes through patient education and integrated care Nowadays, guidelines propagate a personalized, multimodal treatment concept. In addition to prescribing drug therapy that is tailored to the severity of COPD, there are numerous other factors that can be...…
